Cleared Traditional

K071652 - HEMOCUE WBC SYSTEM

K071652 is an FDA 510(k) clearance for HEMOCUE WBC SYSTEM, manufactured by Hemocue AB. The device is a Class 2 Hematology device with product code GKL cleared through the Traditional 510(k) pathway after a 129-day FDA review.

K071652 · Hemocue AB · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2007
Decision
129d
Days
Class 2
Risk

K071652 is an FDA 510(k) clearance for the HEMOCUE WBC SYSTEM. Classified as Counter, Cell, Automated (particle Counter) (product code GKL), Class II - Special Controls.

Submitted by Hemocue AB (Lake Forest, US). The FDA issued a Cleared decision on October 25, 2007 after a review of 129 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5200 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Hemocue AB devices

FDA 510(k) Submission Details - K071652

510(k) Number K071652 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 2007
Decision Date October 25, 2007
Days to Decision 129 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
16d slower than avg
Panel avg: 113d · This submission: 129d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKL Device Classification - Class 2, Special Controls

Product Code GKL Counter, Cell, Automated (particle Counter)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKL Counter, Cell, Automated (particle Counter)

All 97
Devices cleared under the same product code (GKL) and FDA review panel - the closest regulatory comparables to K071652.
Glocyte Automated Cell Counter System
K152776 · Advanced Instruments, Inc. · May 2016
MODIFICATION TO BAYER ADVIA 2120 HEMATOLOGY ANALYZER WITH AUTOSLIDE SYSTEM
K051693 · Bayer Healthcare, LLC · Dec 2005
SYSMEX POCH-100I
K032677 · Sysmex America, Inc. · Feb 2004
ADVIA 120 HEMATOLOGY SYSTEM, CEREBROSPINAL FLUID METHOD
K022331 · Bayer Diagnostics Corp. · Sep 2002
COULTER Z2 ANALYZER
K991070 · Coulter Corp. · May 1999
SYSMEX R-3500, AUTOMATED RETICCULOCYTE ANALYZER, MODEL R-3500
K981950 · Sysmex Corp. · Nov 1998